Marshall Wace’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$345K Hold
2024
Q2
$828K Buy
2024
Q1
$854K Buy
2023
Q4
$193K Buy
2023
Q2
Sell
2023
Q1
$81.6K Buy
2022
Q2
Sell
2022
Q1
$97K Buy
2021
Q4
Sell
2021
Q3
$820K Sell
2021
Q2
$1.61M Buy
2021
Q1
Sell
2020
Q4
$504K Buy
2020
Q3
Sell
2020
Q2
$261K Buy
2018
Q2
Sell
2018
Q1
$170K Buy